BC-10-SB73_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, 3-((4-(1-Isopropyl-1H-pyrrolo[2,3-c]pyridin-3-yl)pyrimidin-2-yl)amino)-4-methylbenzamide, NFkappaB-inducing kinase (NIK;MAP3K14) Inhibitors targeting MAP3K14 (Novartis, 45279469)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/45279469
Similar Terms
Downloads & Tools

Genes

8 genes differentially expressed following the BC-10-SB73_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
MYL6B myosin, light chain 6B, alkali, smooth muscle and non-muscle 1.07951
NT5DC2 5'-nucleotidase domain containing 2 1.06245
RNASEK ribonuclease, RNase K 0.696439
RACK1 receptor for activated C kinase 1 0.377136
RNPS1 RNA binding protein S1, serine-rich domain 0.370887
CCT7 chaperonin containing TCP1, subunit 7 (eta) 0.29407

decreased expression

Symbol Name Standardized Value
ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein -0.334508
ZNF740 zinc finger protein 740 -0.332801